John Barbieri, MD, MBA
@drjohnbarbieri.bsky.social
Derm @bwhdermatology (acne, epi, patient-reported outcomes, antibiotic stewardship, high-value care). Assoc Ed @JAMADerm. Views are mine, not medical advice.
The SD-ACNE trial is a study comparing doxycycline versus spironolactone for women ages 16-40, and is currently enrolling in AR, FL, MA, NY, OH, OR, PA, TX, and VA. To learn more, visit:
clinicalresearch.pennmedicine.org/us/en/listin...
clinicalresearch.pennmedicine.org/us/en/listin...
November 16, 2024 at 7:17 PM
The SD-ACNE trial is a study comparing doxycycline versus spironolactone for women ages 16-40, and is currently enrolling in AR, FL, MA, NY, OH, OR, PA, TX, and VA. To learn more, visit:
clinicalresearch.pennmedicine.org/us/en/listin...
clinicalresearch.pennmedicine.org/us/en/listin...